Vancomycin has been used as the last resort in the clinical treatment of serious Staphylococcus aureus infections. Vancomycin-intermediate S. aureus (VISA) was discovered almost two decades ago. Aside from the vancomycin-intermediate phenotype, VISA strains from the clinic or laboratory exhibited common characteristics, such as thickened cell walls, reduced autolysis, and attenuated virulence. ...

Novel factors involved in Mycobacteria antibiotics resistance are crucial for better targets to combat the ever-increasing drug resistant strains. Mycobacterium tuberculosis Rv1152, a novel GntR family transcriptional regulator and a promising vancomycin adjuvant target, was firstly characterized in our study. Overexpression of Rv1152 in Mycobacterium smegmatis decreased bacterial susceptibilit...

Vancomycin is a glycopeptide antibiotic used for the treatment of Gram-positive bacterial infections. Traditionally, it has been used as a drug of last resort; however, clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) strains with decreased susceptibility to vancomycin (vancomycin intermediate-resistant S. aureus [VISA]) and more recently with high-level vancomycin resist...

BACKGROUND High rates of vancomycin failure in methicillin-resistant Staphylococcus aureus (MRSA) infections have been increasingly reported over time. The primary objective of our study was to determine the impact of vancomycin exposure and outcomes in patients with MRSA bacteremia initially treated with vancomycin. METHODS This was a single-center retrospective analysis of 320 patients with...

The purpose of this study is to determine the pharmacokinetic parameters of vancomycin in Egyptian paediatric oncology patients and to evaluate the factors that influence the variability of the pharmacokinetic parameters in this population. Vancomycin serum concentration at steady state was determined in 51 paediatric cancer patients who were treated with vancomycin multiple intravenous infusio...

BACKGROUND The high prevalence of methicillin-resistant S. aureus (MRSA) has led clinicians to select antibiotics that have coverage against MRSA, usually vancomycin, for empiric therapy for suspected staphylococcal infections. Clinicians often continue vancomycin started empirically even when methicillin-susceptible S. aureus (MSSA) strains are identified by culture. However, vancomycin has be...

and people with permanent prostheses. its increased resistance to antibiotics has created a serious challenge for healthcare system. this study was conducted to determine the pattern of antibiotic-resistance of s. epidermidis isolates from clinical samples.   methods :   during nine months, 251 clinical samples isolated from strains of s. epidermidis were examined. following identification of i...

b a ckground: s taphylococcus aureus (s. aureus) has remained always an important pathogen of common infections acquired in community and as  well as serious nosocomial infections. with advent of penicillins and cephalosporins, infections could be effectively treated, but with the global emergence of methicillin resistant staphylococcus aureus strains (mrsa) physicians were  again left  with li...

background: due (drug utilization evaluation) studies can help identify and correct problems associated with irrational use of drugs. considering lack of data regarding how rational vancomycin is being used, we evaluated this due study in a referral infectious center to evaluate compliance with guidelines in terms of rational use of this valuable antibiotic. methods: this retrospective study wa...

BACKGROUND Recent reports have described decreased effectiveness with vancomycin treatment for methicillin-resistant Staphylococcus aureus bacteremia (MRSAB) when the vancomycin minimum inhibitory concentration (MIC) is >1 µg/mL. METHODS This matched, retrospective cohort study compared the clinical effectiveness of daptomycin with that of vancomycin for the treatment of MRSAB with vancomycin...